Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01668719 |
|---|---|
| Brief Title: | S1211 Bortezomib, Dexamethasone, and Lenalidomide With or Without Elotuzumab in Treating Patients With Newly Diagnosed High-Risk Multiple Myeloma |
| First Submitted : | August 16, 2012 |
| First Submitted that Met QC Criteria : | August 16, 2012 |
| First Posted : | August 20, 2012 (Estimate) |
| Results First Submitted : | June 8, 2021 |
| Results First Submitted that Met QC Criteria : | October 25, 2021 |
| Results First Posted : | October 27, 2021 |
| Last Update Submitted that Met QC Criteria : | May 19, 2023 |
| Last Update Posted : | May 23, 2023 |